Biomira's Truquant test cleared by US panel:
This article was originally published in Clinica
Executive Summary
The US FDA's Immunology Devices Advisory Panel has unanimously recommended approval of Biomira's (Canada) Truquant BR RIA blood test for the detection of recurrent breast cancer. The panel recommended approval on September 21st, subject to certain conditions being met.